Laboratory Reagents

The purpose of Amendment SPE2DS-22-Q-0083-0002 is to: 1. Update the Attachment 1 items list with the following changes: Lot 1-Line 2: Manufacturer Part Nr. 07P02-13 is corrected to read Nr.: 400-0031 Lot 2-Line 22: Manufacturer Part Nr. 7D2947 is now added to Lot 3 – Line 24 and is an ALERE item Lot 2-Line 23: Manufacturer Part Nr. 8547135A is now added to Lot 4 - Line 30 and is a BECKMAN-COULTER item 2. Clarify information regarding requested Manufacturer Production Schedules as part of the proposal package: The Government is not requesting manufacturing plans for the entire plant. We only request the production schedules issued by the manufacturer for items you are going to quote on Attachment 1. The schedules are not required with your quotation but may be submitted to facilitate the Government’s technical evaluation of your quote. The Government does not need the schedule to include every detail from raw material to end product. However, the manufacturers’ schedules submitted by the Quoter should include the earliest dates the quoted items will be available for order. See the SF30 attached. The purpose of amendment SPE2DS-22-Q-0083-0001 is to: 1. Post Q&A 2. Add Clause 52.225-5, Trade Agreements (Oct 2019) by reference under Clause 52.212-5. 3. Add Attachment 6: Acronym Definitions 4. Revise Column Headings in Attachment 1 5. Revise Addendum to 52.212-1, Instructions to Offerors, Volume III - Price 6. Revise Addendum to 52.212-2, Evaluation - Commercial Items, Factor - 3 Price 7. Extend the response deadline from 22 August 2022 to 6 September 2022 at 14:00 local time. See the SF30 attached. Defense Logistics Agency (DLA) Troop Support Europe and Africa has a new requirement to establish one or more Indefinite Delivery / Indefinite Quantity (IDIQ) contracts for various brand-name laboratory reagents with delivery to the United States Army Medical Center Europe (USAMMCE). The contract(s) will support USAMMCE’s customer demand for reagents, controls, and test kits for use on analyzers at various locations. The term of the contract(s) awarded from this solicitation will be a 5-year ordering period. The minimum value of resulting contract(s) is $1,000.00. The Maximum Dollar Value for each contract will be established by the Government prior to award of a contract but will not exceed $2.5M. This solicitation does not include purchase of equipment or incidental services. This Request for Quotes (RFQ) is unrestricted and conducted under procedures at FAR Part 13, Simplified Acquisition Procedures. The applicable NAICS code is 325413 – In Vitro Diagnostic Substance Manufacturing with the small Business size standard of 1200 Employees. Location for the delivery is: USAMMCE BUILDING 2369 Ludwigshafenerstr. 31 67657, Kaiserslautern GERMANY All information for the RFQ is included In this announcement. No hard copies of the solicitation will be provided. Any amendments to this solicitation will be available at this website. Quoters are responsible obtaining amendments to this solicitation prior to the time of responding to the solicitation. Quotations are due by 14:00 Central European Time on Monday, August 22, 2022. Questions: shall be submitted in one email to elena.raspitha@dla.mil and kevin.rafferty@dla.mil no later than, July 28, 2022 at 14:00 Central European Time. Telephonic inquiries will not be entertained. Questions will be answered via written amendment and published to this site. A virtual pre-proposal conference is tentatively scheduled for Thursday, August 4, 2022, at 14:00 CET. All interested parties who submit questions by the cut-off date or add themselves to the “Interested Vendors List” on sam.gov will receive dial-in instructions via email. Interested parties are strongly encouraged to follow this opportunity by clicking the “follow” icon on the top right corner of this announcement.